CD34+ cells from bone marrow mononuclear cells of other 4 newly diagnosed patients with AML were sorted into TIM-3+ and TIM-3− cells and subjected to transcriptome sequencing. This evidence concerns the gene HAVCR2 and acute myeloid leukemia.